These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 16327857

  • 1. [Are children getting the right drugs?].
    Bratlid D.
    Tidsskr Nor Laegeforen; 2005 Dec 01; 125(23):3290-2. PubMed ID: 16327857
    [Abstract] [Full Text] [Related]

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 01; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The economics of pediatric formulation development for off-patent drugs.
    Milne CP, Bruss JB.
    Clin Ther; 2008 Nov 01; 30(11):2133-45. PubMed ID: 19108801
    [Abstract] [Full Text] [Related]

  • 5. Development of medicines for children in Europe: ethical implications.
    Saint Raymond A, Brasseur D.
    Paediatr Respir Rev; 2005 Mar 01; 6(1):45-51. PubMed ID: 15698816
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Towards evidence-based pharmacotherapy in children.
    Kemper EM, Merkus M, Wierenga PC, Van Rijn PC, Van der Werff D, Lie-A-Huen L, Offringa M.
    Paediatr Anaesth; 2011 Mar 01; 21(3):183-9. PubMed ID: 21199133
    [Abstract] [Full Text] [Related]

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE, Kleijnen J.
    Eur J Health Econ; 2008 Nov 01; 9 Suppl 1():5-29. PubMed ID: 18987905
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ethical issues of clinical trials in children: a European perspective.
    Sammons H.
    Arch Dis Child; 2009 Jun 01; 94(6):474-7. PubMed ID: 19208673
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA, McNeil DA, Maloff B, Mutasingwa D, Wu M, Ford C, Tough SC.
    Obes Rev; 2006 Feb 01; 7 Suppl 1():7-66. PubMed ID: 16371076
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changing requirements for evaluation of pharmacologic agents.
    Chesney RW, Christensen ML.
    Pediatrics; 2004 Apr 01; 113(4 Suppl):1128-32. PubMed ID: 15060209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.